Hadassah Medical CenterJerusalem, Yerushalayim, Israel
Disclosure information not submitted.
ORF37-02 - Transforming Anabolic Treatments for Osteoporosis: New Clinical Data Supports a Single EB613 Tablet [Oral PTH(1-34)] as the Final Candidate for a Phase 3 Study
Sunday, June 14, 20263:30 PM - 4:15 PM CT